account_balance
Investment manager · 13F filer · SEC CIK 816788
Tanaka Capital Management Inc
Reported value$59.9Mas of Mar 31, 2026
Positions43
Top 10 weight64.6%UAMY alone is 9%
FiledMay 1848 days after quarter end
Portfolio · as of Mar 31, 2026
Where the money is
UAMYUnited States Antimony Corp
9.0%
NXENexGen Energy Ltd.
8.5%
CORTCorcept Therapeutics Inc
7.5%
NVDANVIDIA Corp
7.2%
Aura Minerals, Inc.
6.8%
NUVBNuvation Bio Inc.
6.5%
AAPLApple Inc.
5.4%
IJRiShares Core SP Small Cap
4.7%
CPRXCatalyst Pharmaceuticals
4.7%
ONTOOnto Innovation Inc.
4.3%
AMATApplied Materials Inc
4.0%
CCJCameco Corp
3.9%
UAMYUnited States Antimony Corp
9.0%
NXENexGen Energy Ltd.
8.5%
CORTCorcept Therapeutics Inc
7.5%
NVDANVIDIA Corp
7.2%
NUVBNuvation Bio Inc.
6.5%
AAPLApple Inc.
5.4%
IJRiShares Core SP Small Cap
4.7%
CPRXCatalyst Pharmaceuticals
4.7%
Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
UAMY United States Antimony Corp 9.0% NXE NexGen Energy Ltd. 8.5% CORT Corcept Therapeutics Inc 7.5% NVDA NVIDIA Corp 7.2%
Aura Minerals, Inc. 6.8%
NUVB Nuvation Bio Inc. 6.5% AAPL Apple Inc. 5.4% IJR iShares Core SP Small Cap 4.7%
CPRX Catalyst Pharmaceuticals 4.7%
ONTO Onto Innovation Inc. 4.3% AMAT Applied Materials Inc 4.0% CCJ Cameco Corp 3.9% Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.